Cafepharma Today

June 13 2025 - Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Merck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
Moderna falls on doubts over new CDC panel's backing of RSV vaccine
Urogen’s bladder cancer drug wins FDA approval over adcomm’s objections
A day in the life of GSK’s U.S. president
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Bloomberg
Monday, June 27, 2011 - 5:53pm
tags:
Brilinta, AstraZeneca, aspirin, Plavix, Sanofi, Bristol-Myers Squibb
Pleasure And Pain For Pfizer
Investopedia
Monday, June 27, 2011 - 5:47pm
tags:
Pfizer, Pain Therapeutics, Durect Corporation, JNJ, Abbott Laboratories, Acura Pharmaceuticals
Biotech Clinical Trials Update for 3 Drug Manufacturers
Seeking Alpha
Monday, June 27, 2011 - 5:44pm
tags:
Pfizer, Cel-Sci, Bristol-Myers Squibb, Eliquis, Multikine
As Ph3 failures spike Big Pharma hits the brakes on R&D spending
Fierce Biotech
Monday, June 27, 2011 - 10:44am
tags:
Big Pharma, R&D
[video] State of Biotech: Human Genome Sciences
CNBC
Monday, June 27, 2011 - 10:42am
tags:
Human Genome Sciences
Zyprexa Suit Appeal Rejected by High Court in Victory for Lilly
Bloomberg
Monday, June 27, 2011 - 10:39am
tags:
Zyprexa, Eli Lilly, schizophrenia
Icagen rockets 130% on Pfizer talks
Marketwatch
Monday, June 27, 2011 - 10:37am
tags:
Icagen, Pfizer, M&A
Life Technologies Ties Up with Pharma Majors
Yahoo/Zacks.com
Monday, June 27, 2011 - 10:36am
tags:
Life Technologies, AstraZeneca, Illumina, JNJ
It May Be Time to Throttle Back on Oncothyreon
Seeking Alpha
Monday, June 27, 2011 - 9:27am
tags:
Oncothyreon, Dendreon, ImmunoCellular, Merck KGaA
Watson Files More ANDAs
Yahoo/Zacks.com
Monday, June 27, 2011 - 9:22am
tags:
ANDAs, Watson Pharmaceuticals, GSK, Novartis, Pfizer, Adovart, nabumetone, Pataday
US Supreme Court throws out pharma data sales ban
Pharma Times, UK
Monday, June 27, 2011 - 9:00am
tags:
Supreme Court, data mining
Doing Deals With Biotechs Fails To Yield Results?
Pharmalot
Monday, June 27, 2011 - 8:55am
tags:
biotech
Dendreon: Key Catalysts in Play
Seeking Alpha
Monday, June 27, 2011 - 8:52am
tags:
Dendreon, prostate cancer, Provenge
FDA Appeals Panel to Hold Avastin Hearing This Week
WSJ Online
Monday, June 27, 2011 - 8:50am
tags:
FDA, Avastin, Roche, breast cancer
Collplant Jumps Most in 7 Months on Development With Pfizer
Bloomberg
Sunday, June 26, 2011 - 12:11pm
tags:
Collplant, Pfizer
Collplant, Pfizer Complete First Stage of Development Project
Bloomberg
Sunday, June 26, 2011 - 12:10pm
tags:
Collplant, Pfizer
Bristol-Myers, AstraZeneca Diabetes Drug Shows Bladder, Breast Cancer Risk
Bloomberg
Sunday, June 26, 2011 - 12:09pm
tags:
Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, diabetes
Medicine's Next Revolution: 2 Cancer Vaccines With the Greatest Potential
Seeking Alpha
Sunday, June 26, 2011 - 12:03pm
tags:
Dendreon, prostate cancer, DN24-02, Neuvenge, Provenge, Oncothyreon, Stimuvax, colorectal cancer, breast cancer, Keryx
The Next Big Thing In Biotech: Dendreon
The Street
Sunday, June 26, 2011 - 11:59am
tags:
Dendreon
The 5 Companies in the Pharmaceuticals Industry With the Lowest P/E Ratio (SKBI, BSPM, DEPO, POZN, LLY)
Investor's Business Daily
Saturday, June 25, 2011 - 9:08pm
tags:
Skystar Bio-Pharmaceutical, Pozen, Biostar Pharmaceuticals, Depomed

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.